Human INO80/YY1 chromatin remodeling complex transcriptionally regulates the BRCA2- and CDKN1A-interacting protein (BCCIP) in cells

Abstract

The BCCIP (BRCA2- and CDKN1A-interacting protein) is an important cofactor for BRCA2 in tumor suppression. Although the low expression of BCCIP is observed in multiple clinically diagnosed primary tumor tissues such as ovarian cancer, renal cell carcinoma and colorectal carcinoma, the mechanism of how BCCIP is regulated in cells is still unclear. The human INO80/YY1 chromatin remodeling complex composed of 15 subunits catalyzes ATP-dependent sliding of nucleosomes along DNA. Here, we first report that BCCIP is a novel target gene of the INO80/YY1 complex by presenting a series of experimental evidence. Gene expression studies combined with siRNA knockdown data locked candidate genes including BCCIP of the INO80/YY1 complex. Silencing or over-expressing the subunits of the INO80/YY1 complex regulates the expression level of BCCIP both in mRNA and proteins in cells. Also, the functions of INO80/YY1 complex in regulating the transactivation of BCCIP were confirmed by luciferase reporter assays. Chromatin immunoprecipitation (ChIP) experiments clarify the enrichment of INO80 and YY1 at+0.17 kb downstream of the BCCIP transcriptional start site. However, this enrichment is significantly inhibited by either knocking down INO80 or YY1, suggesting the existence of both INO80 and YY1 is required for recruiting the INO80/YY1 complex to BCCIP promoter region. Our findings strongly indicate that BCCIP is a potential target gene of the INO80/YY1 complex.

Keywords

BCCIP / human INO80 / chromatin remodeling complex

References

[1] Ashburner M, Ball CA, Blake JA, Botstein D, Butler H, Cherry JM (2000) Gene ontology: tool for the unification of biology. The gene ontology consortium. Nat Genet 25:25–29

[2] Cai Y, Jin J, Yao T, Gottschalk AJ, Swanson SK, Wu S, Shi Y, Washburn MP, Florens L, Conaway RC, ConawayJW (2007) YY1 functions with INO80 to activate transcription. Nat Struc Mol Biol 14:872–874

[3] Cao L, Ding J, Dong L, Zhao J, Su J, Wang L, Sui Y, Zhao T, Wang F, Jing J, Cai Y (2015) Negative regulation of p21Waf1/Cip1 by human INO80 chromatin remodeling complex is implicated in cell cycle phase G2/M arrest and abnormal chromosome stability. PLoS ONE 10(9):e0137411.

[4] Chen L, Cai Y, Jin J, Florens L, Swanson SK, Washburn MP, Conaway JW, Conaway RR (2011) Subunit organization of the human INO80 chromatin remodeling complex: an evolutionarily conserved core complex catalyzes ATP-dependent nucleosome remodeling. J Biol Chem 286:11283–11289

[5] Chen L, Conaway RC, Conaway JW (2013) Multiple modes of regulation of the human Ino80 SNF2 ATPase by subunits of the INO80 chromatin remodeling complex. Proc Natl Acad Sci USA 110:20497–20502

[6] Conaway RC, Conaway JW (2009) The INO80 chromatin remodeling complex in transcription, replication and repair. Trends Boichem Sci 34:71–77

[7] da Huang W, Sherman BT, Lempicki RA (2009a) Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 4:44–57

[8] da Huang W, Sherman BT, Lempicki RA (2009b) Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists. Nucleic Acids Res 37:1–13

[9] Hariharan N, Kelley DE, Perry RP (1991) Delta a transcription factor that binds to downstream elements in several polymerase II promoters, is a functionally versatile zinc finger protein. Proc Natl Acad Sci USA 88:9799–9803

[10] Jin J, Cai Y, Yao T, Gottschalk AJ, Florens L, Swanson SK, Gutierrez J, Coleman MK, Workman JL, Mushegian A, Washburn MP, Conaway RC, Conaway JW (2005) A mammalian chromatin remodeling complex with similarities to the yeast INO80 complex. J Biol Chem 280:41207–41212

[11] Karolchik D, Barber GP, Casper J, Clawson H, Cline MS, Diekhans M, Dreszer TR, Fujita PA, Guruvadoo L, Haeussler M, Harte RA, Heitner S, Hinrichs AS, Learned K, Lee BT, Li CH, Raney BJ, Rhead B, Rosenbloom KR, Sloan CA, Speir M, Zweig AS, Haussler D, Kuhn RM, Kent WJ (2013) The UCSC genome vrowser database: 2014 update. Nucleic Acids Res1–7

[12] Lee JS, Galvin KM, See RH, Eckner R, Livingston D, Moran E, Shi Y (1995) Relief of YY1 transcriptional repression by adenovirus E1A is mediated by E1A-associated protein p300. Genes Dev 9:1188–1198

[13] Liu J, Yuan Y, Huan J, Shen Z (2001) Inhibition of breast and brain cancer cell growth by BCCIP alpha, an evolutionary conserved nuclear protein that interacts with BRCA2. Oncogene 20:336–345

[14] Liu X, Cao L, Ni J, Liu N, Zhao X, Wang Y, Zhu L, Wang L, Wang J, Yue Y, Cai Y, Jin J (2013) Differential BCCIP gene expression in primary human ovarian cancer, renal cell carcinoma, and colorectal cancer tissues. Int J Oncol 43:1925–1934

[15] Lu H, Guo X, Meng X, Liu J, Allen X, Wray J, Nickoloff JA, Shen Z (2005) The BRCA2-interacting protein BCCIP functions in RAD51 and BRCA2 focus formation and homologous recombinational repair. Mol Cell Biol 25:1949–1957

[16] Meng X, Liu J, Shen Z (2003) Genomic structure of the human BCCIP gene and its expression in cancer. Gene 302:139–146

[17] Meng X, Liu J, Shen Z (2004a) Injibition of G1 to S cell cycle progression by BCCIP beta. Cell Cycle 3:343–348

[18] Meng X, Lu H, Shen Z (2004b) BCCIP functions through p53 to regulate the expression of p21Waf1/Cip1. Cell Cycle 3:1457–1462

[19] Meng X, Fan J, Shen Z (2007) Roles of BCCIP in chromosome stability and cytokinesis. Oncogene 26:6253–6260

[20] Morrison AJ, Shen X (2009) Chromatin remodeling beyond transcription: the INO80 and SWR1 complexes. Nat Rev Mol Biol 10:373–384

[21] Moshkin YM, Chalkley GE, Kan TW, Reddy BA, Ozgur Z, van Ijcken WF, Dekkers DH, Demmers JA, Travers AA, Verrijzer CP (2012) Remodelers organize cellular chromatin by counteracting intrinsic histone-DNA sequence preferences in a class-specific manner. Mol Cell Biol 32:675–688

[22] Neuman SD, Ihry RJ, Gruetzmacher KM, Bashirullah A (2014) INO80-dependent repression of ecdysone-induced transcriptional responses regulates developmental timing in Drosophila. Dev Biol 387:229–239

[23] Ogata H, Goto S, Sato K, Fujibuchi W, Bono H, Kanehisa M (1999) KEGG: kyoto encyclopedia of genes and genomes. Nucleic Acids Res 27:29–34

[24] Ono T, Kitaura H, Ugai H, Murata T, Yokoyama KK, Iguchi-Ariga SM, Ariga H (2000) Tok-1, a novel p21Cip1-binding protein that cooperatively enhances p21-dependent inhibitory activity toward CDK2 kinase. J Biol Chem 275:31145–31154

[25] Park K, Atchison ML (1991) Isolation of a candidate repressor/activator, NF-E1 (YY-1, delta), that binds to the immunoglobulin kappa 3′ enhancer and the immunoglobulin heavy-chain mu E1 site. Proc Natl Acad Sci USA 88:9804–9808

[26] Seeber A, Hauer M, Gasser SM (2013) Nucleosome remodelers in double-strand break repair. Curr Opin Genet Dev 23:174–184

[27] Seto E, Shi Y, Shenk T (1991) YY1 is an initiator sequence-binding protein that directs and activates transcription in vitro. Nature 354:241–245

[28] Shen X, Ranallo R, Choi E, Wu C (2003) Involvement of actinrelated proteins in ATP-dependent chromatin remodeling. Mol Cell 12:147–155

[29] Shi Y, Seto E, Chang LS, Shenk T (1991) Transcriptional repression by YY1, a human GLI-Kruppel- related protein, and relief of repression by adenovirus E1A protein. Cell 67:377–388

[30] Shi Y, Lee JS, Galvin KM (1997) Everything you have ever wanted to know about Yin Yang 1. Biochim Biophys Acta 1332:F49–F66

[31] Thomas MJ, Seto E (1999) Unlocking the mechanisms of transcription factor YY1: Are chromatin modifying enzymes the key? Gene 236:197–208

[32] Wang L, Du Y, Ward JM, Shimbo T, Lackford B, Zheng X, Miao YL, Zhou B, Han L, Fargo DC, Jothi R, William CJ, Wade PA, Hu G (2014) INO80 facilitates pluripotency gene activation in embryonic stem self-renewal, reprogramming, and blastocyst development. Cell Stem Cell 14:575–591

[33] Wu D, Zhang R, Zhao R, Chen G, Cai Y, Jin J (2013) A novel function of novobiocin: disrupting the interaction of HIF1α and p300/CBP through direct binding to the HIF1α C-ternimal activation domain. PLoS One 8:e62014

[34] Yao YL, Yang WM, Seto E (2001) Regulation of transcription factor YY1 by acetylation and deacetylation. Mol Cell Biol 21:5979–5991

RIGHTS & PERMISSIONS

The Author(s) 2016. This article is published with open access at Springerlink.com and journal.hep.com.cn